Literature DB >> 23826889

Effects of asparagine mutagenesis of conserved aspartic acids in helix 2 (D2.50) and 3 (D3.32) of M1-M4 muscarinic receptors on the irreversible binding of nitrogen mustard analogs of acetylcholine and McN-A-343.

Hinako Suga1, Frederick J Ehlert.   

Abstract

We investigated how asparagine mutagenesis of conserved aspartic acids in helix 2 (D2.50) and 3 (D3.32) of M1-M4 muscarinic receptors alters the irreversible binding of acetylcholine mustard and BR384 (4-[(2-bromoethyl)methyl-amino]-2-butynyl N-(3-chlorophenyl)carbamate), a nitrogen mustard derivative of McN-A-343 ([4-[[N-(3-chlorophenyl)carbamoyl]oxy]-2-butynyl] trimethylammonium chloride). The D2.50N mutation moderately increased the affinity of the aziridinium ions of acetylcholine mustard and BR384 for M2-M4 receptors and had little effect on the rate constant for receptor alkylation. The D3.32N mutation greatly reduced the rate constant for receptor alkylation by acetylcholine mustard but not by BR384, although the affinity of BR384 was reduced. The combination of both mutations (D2.50N/D3.32N) substantially reduced the rate constant for receptor alkylation by BR384 relative to that of wild type and mutant D2.50N and D3.32N receptors. The change in binding affinity caused by the mutations suggests that the D2.50N mutation alters the interaction of acetylcholine mustard with D3.32 of the M1 and M3 receptors but not that of the M4 receptor. BR384 exhibited the converse relationship. The simplest explanation is that acetylcholine mustard and BR384 alkylate at least two residues on M1-M4 receptors and that the D2.50N mutation alters the rate of alkylation of D3.32 relative to another residue, perhaps D2.50 itself.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23826889      PMCID: PMC3855626          DOI: 10.1021/bi4003698

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  37 in total

Review 1.  Structural mimicry in G protein-coupled receptors: implications of the high-resolution structure of rhodopsin for structure-function analysis of rhodopsin-like receptors.

Authors:  J A Ballesteros; L Shi; J A Javitch
Journal:  Mol Pharmacol       Date:  2001-07       Impact factor: 4.436

Review 2.  Structure and activation of muscarinic acetylcholine receptors.

Authors:  E C Hulme; Z L Lu; J W Saldanha; M S Bee
Journal:  Biochem Soc Trans       Date:  2003-02       Impact factor: 5.407

3.  Evidence for a tandem two-site model of ligand binding to muscarinic acetylcholine receptors.

Authors:  J Jakubik; E E El-Fakahany; S Tucek
Journal:  J Biol Chem       Date:  2000-06-23       Impact factor: 5.157

4.  Distribution of bound 3 H-benzilylcholine mustard in subcellular fractions of smooth muscle from guinea-pig ileum.

Authors:  C Fewtrell; H P Rang
Journal:  Br J Pharmacol       Date:  1971-10       Impact factor: 8.739

5.  Muscarinic receptor subtypes: M1 and M2 biochemical and functional characterization.

Authors:  R Hammer; A Giachetti
Journal:  Life Sci       Date:  1982-12-27       Impact factor: 5.037

6.  The binding of a 2-chloroethylamine derivative of oxotremorine (BM 123) to muscarinic receptors in the rat cerebral cortex.

Authors:  F J Ehlert; D J Jenden
Journal:  Mol Pharmacol       Date:  1985-08       Impact factor: 4.436

7.  Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.

Authors:  Y Cheng; W H Prusoff
Journal:  Biochem Pharmacol       Date:  1973-12-01       Impact factor: 5.858

8.  Cardiac muscarinic cholinergic receptor binding is regulated by Na+ and guanyl nucleotides.

Authors:  L B Rosenberger; H I Yamamura; W R Roeske
Journal:  J Biol Chem       Date:  1980-02-10       Impact factor: 5.157

9.  Binding of metabolites of cyclophosphamide to DNA in a rat liver microsomal system and in vivo in mice.

Authors:  K Hemminki
Journal:  Cancer Res       Date:  1985-09       Impact factor: 12.701

10.  Structural basis for allosteric regulation of GPCRs by sodium ions.

Authors:  Wei Liu; Eugene Chun; Aaron A Thompson; Pavel Chubukov; Fei Xu; Vsevolod Katritch; Gye Won Han; Christopher B Roth; Laura H Heitman; Adriaan P IJzerman; Vadim Cherezov; Raymond C Stevens
Journal:  Science       Date:  2012-07-13       Impact factor: 47.728

View more
  2 in total

1.  Allosteric sodium in class A GPCR signaling.

Authors:  Vsevolod Katritch; Gustavo Fenalti; Enrique E Abola; Bryan L Roth; Vadim Cherezov; Raymond C Stevens
Journal:  Trends Biochem Sci       Date:  2014-04-21       Impact factor: 13.807

Review 2.  Harnessing Ion-Binding Sites for GPCR Pharmacology.

Authors:  Barbara Zarzycka; Saheem A Zaidi; Bryan L Roth; Vsevolod Katritch
Journal:  Pharmacol Rev       Date:  2019-10       Impact factor: 25.468

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.